Nirmatrelvir / Ritonavir

Common brands: Paxlovid, Tylenol Extra Strength, Tylenol Regular Strength, Acid Reducer, Vitamin D

Top reporter: Pfizer Laboratories Div Pfizer Inc

Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Expectorant [EPC]HMG-CoA Reductase Inhibitor [EPC]Provitamin D2 Compound [EPC]
53,422
Total Reports
53,193
Serious Reports
548
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.03%)

Patient Demographics

Male
16,958
Female
31,004

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Nirmatrelvir / Ritonavir.

# Reaction Reports % of Total
1 COVID-19 22,798
26.2%
2 DISEASE RECURRENCE 20,098
23.1%
3 DYSGEUSIA 7,339
8.4%
4 DIARRHOEA 4,022
4.6%
5 NAUSEA 2,631
3.0%
6 HEADACHE 2,170
2.5%
7 COUGH 2,044
2.4%
8 FATIGUE 2,011
2.3%
9 INCORRECT DOSE ADMINISTERED 1,700
2.0%
10 VOMITING 1,401
1.6%
11 MALAISE 1,371
1.6%
12 NASAL CONGESTION 1,367
1.6%
13 OFF LABEL USE 1,320
1.5%
14 DRUG INTERACTION 1,277
1.5%
15 PYREXIA 1,251
1.4%
16 OROPHARYNGEAL PAIN 1,248
1.4%
17 DIZZINESS 1,197
1.4%
18 RHINORRHOEA 1,090
1.3%
19 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1,077
1.2%
20 PAIN 1,060
1.2%
21 TASTE DISORDER 1,043
1.2%
22 SYMPTOM RECURRENCE 993
1.1%
23 FEELING ABNORMAL 967
1.1%
24 INSOMNIA 867
1.0%
25 ILLNESS 833
1.0%
26 ABDOMINAL PAIN UPPER 813
0.9%
27 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 750
0.9%
28 DYSPNOEA 744
0.9%
29 RASH 744
0.9%
30 INCORRECT PRODUCT ADMINISTRATION DURATION 736
0.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.